SANUWAVE Health (SNWV) Gains from Investment Securities (2014 - 2025)
SANUWAVE Health's (SNWV) quarterly Gains from Investment Securities came in at -$5.9 million in Q4 2025, down 142.97% year-on-year from $13.8 million in Q4 2024, and up 2.89% on a QoQ basis from -$6.1 million in Q3 2025.
SANUWAVE Health (SNWV) Gains from Investment Securities (2014 - 2025) Analysis & Trends
SANUWAVE Health (SNWV) has 12 years of Gains from Investment Securities data on file, last reported at -$5.9 million in Q4 2025.
- On a quarterly basis, Gains from Investment Securities fell 142.97% year-over-year to -$5.9 million in Q4 2025; TTM through Mar 2026 was -$13.0 million, a 138.47% decrease from a year earlier, with the FY2025 full-year figure at -$8.1 million, down 125.81% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$5.9 million, up from -$6.1 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for SNWV reached as high as $19.3 million in Q3 2023 and fell as low as -$20.3 million in Q4 2023.
- Historically, Gains from Investment Securities has averaged $1.8 million across 5 years, with a median of -$22000.0 in 2021.
- Across the five-year window, Gains from Investment Securities tumbled 1430.12% in 2022 and soared 467.81% in 2023, its largest moves.
- Year by year, Gains from Investment Securities stood at $4.2 million in 2021, then jumped by 315.33% to $17.5 million in 2022, then slumped by 215.92% to -$20.3 million in 2023, then surged by 167.81% to $13.8 million in 2024, then tumbled by 142.97% to -$5.9 million in 2025.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$5.9 million in Q4 2025, -$6.1 million in Q3 2025, and -$990000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | SANUWAVE Health | 52.31 Mn | 41.53 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.92 Mn |
| Dec 31, 2025 | -5.92 Mn |
| Sep 30, 2025 | -6.10 Mn |
| Sep 30, 2025 | -6.10 Mn |
| Jun 30, 2025 | -990,000.00 |
| Jun 30, 2025 | -990,000.00 |
| Mar 31, 2025 | 4.90 Mn |
| Mar 31, 2025 | 4.90 Mn |
| Dec 31, 2024 | 13.78 Mn |
| Dec 31, 2024 | 13.78 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Jun 30, 2024 | -3.72 Mn |
| Jun 30, 2024 | -3.72 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | -20.32 Mn |
| Dec 31, 2023 | -20.32 Mn |
| Sep 30, 2023 | 19.33 Mn |
| Sep 30, 2023 | 19.33 Mn |